Filing Details
- Accession Number:
- 0001179110-15-001100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-21 20:29:45
- Reporting Period:
- 2015-01-16
- Filing Date:
- 2015-01-21
- Accepted Time:
- 2015-01-21 20:29:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1436304 | Kythera Biopharmaceuticals Inc | KYTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1354034 | D Camille Samuels | C/O Kythera Biopharmaceuticals, Inc. 30930 Russell Ranch Road, Suite 300 Westlake Village CA 91362 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-01-16 | 100 | $36.22 | 15,835 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-01-16 | 150 | $37.02 | 15,685 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015.
- Reflects the pro rata distribution of an aggregate of 15,935 shares from Versant Ventures II, LLC to the Reporting Person as follows: 4,519 shares on October 3, 2013, 4,965 shares on October 15, 2013, and 6,451 shares on March 4, 2014. The Reporting Person no longer has beneficial ownership of shares previously reported as indirectly held by Versant Venture Capital II, L.P., Versant Side Fund II, L.P., Versant Affiliates Fund II-A, L.P. and Versant Venture Management LLC.
Billionaire Hedge Funds
